Healthy Heart Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
home > drugs a-z list > optison (perflutren protein-type a microspheres) drug center > optison (perflutren protein-type a microspheres) drug - overdosage and contraindications
Optison
|
|
CONTRAINDICATIONS
Do not administer OPTISON (perflutren protein-type a microspheres) to patients with known or suspected:
- Right-to-left, bi-directional, or transient right-to-left cardiac shunts,
- Hypersensitivity to perflutren, blood, blood products or albumin (see WARNINGS). Do not administer OPTISON (perflutren protein-type a microspheres) by intra-arterial injection.
Last reviewed on RxList: 7/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Next: Drug Description
Additional Optison Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
From WebMD
Optison
Use it Now
Find it Now
Pill Identifier on RxList
- quick,
easy,
concise
Find a Local Pharmacy
- including
24 hour
pharmacies
Updated & New
RxList does not provide medical advice, diagnosis or treatment.